Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01238172 · ClinicalTrials.gov registry record · Phase 3
Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance
A Phase 3 study, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- Phase 3
- Development phase
- 478
- Enrollment target
NCT01238172 is a Phase 3 study that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 478 participants.
The verdict
NCT01238172, a Phase 3 study, has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 478 participants
- Enrollment target
Study Summary
RATIONALE: Eating a diet high in vegetables may slow down disease progression in patients with prostate cancer. PURPOSE: This randomized clinical trial is studying how well diet works in altering disease progression in patients with prostate cancer on active surveillance.
Interventions
- OTHER dietary education and counseling
- OTHER prostate cancer foundation booklet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 478 participants |
| Start Date | 2011-01 |
| Est. Completion | 2019-01-15 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01238172
The ClinicalTrials.gov registry entry for NCT01238172 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 478 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which dietary education and counseling is the first listed.
NCT01238172 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01238172 about?
NCT01238172 is a clinical study titled "Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance". RATIONALE: Eating a diet high in vegetables may slow down disease progression in patients with prostate cancer. PURPOSE: This randomized clinical trial is studying how well diet works in altering disease progression in patients with prostate cancer on active surveillance.
What is the current status of trial NCT01238172?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 478 participants. The study started on 2011-01. Estimated completion is 2019-01-15.
What interventions are being tested in trial NCT01238172?
The interventions under investigation include: dietary education and counseling (OTHER), prostate cancer foundation booklet (OTHER).
Who is sponsoring clinical trial NCT01238172?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.